Your browser doesn't support javascript.
loading
Nanobodies as sensors of GPCR activation and signaling.
El Daibani, Amal; Che, Tao.
Afiliação
  • El Daibani A; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, United States.
  • Che T; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, United States; Center for Clinical Pharmacology, University of Health Sciences and Pharmacy in St. Louis and Washington University School of Medicine, St. Louis, MO, United States. Electronic address: taoche@wustl.edu.
Methods Cell Biol ; 166: 161-177, 2021.
Article em En | MEDLINE | ID: mdl-34752331
ABSTRACT
Nanobodies have emerged as useful tools to study G protein-coupled receptor (GPCR) structure, dynamic, and subcellular localization. Initially, several nanobodies have been developed as chaperones to facilitate GPCR crystallization. To explore their potential as biosensors to monitor receptor activation and dynamics, we here described protocols to characterize nanobody's interaction with GPCRs and their application as probes for protein identification and visualization on the cellular level. We also introduced a chimeric approach to enable a kappa-opioid receptor derived nanobody to bind to other GPCRs, including orphan GPCRs whose endogenous ligand or intracellular transducers are unknown. This approach provides a reporter assay to identify tool molecules to study the function of orphan GPCRs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnicas Biossensoriais / Anticorpos de Domínio Único Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnicas Biossensoriais / Anticorpos de Domínio Único Idioma: En Ano de publicação: 2021 Tipo de documento: Article